CDC25A and glioma: Finally, it is worth mentioning that this study was conducted to experimentally validate the effect of gene CDC25A on temozolomide (TMZ) resistance, which is hoped to provide a reference for the individualized treatment of temozolomide-resistant glioma patients in the clinic.